Order Online! Now! Get your $50 coupon for online order.
Order Online! Now! Get your $50 coupon for online order.
Our limited edition HOLIDAYS LLAMA is here! Place any order now to recieve one!
Earn Loyalty Rewards! Up to $155 Amazon Gift Card
Time Limited Offer: Welcome Gift for New Customers !
Time Limited Offer: Welcome Gift for New Customers !
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
GMP-ILBH16 | Human | GMP Human IL-1 beta Protein | ![]() |
||
CRS-B002 | Human | ClinMax™ Human IL-1β ELISA Kit | |||
ILB-H82E9 | Human | Biotinylated Human IL-1 beta / IL-1F2 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
ILB-H51H3 | Human | Human IL-1 beta / IL-1F2 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
ILB-C51H3 | Cynomolgus | Cynomolgus IL-1 beta / IL-1F2 Protein, His Tag | ![]() |
![]() ![]() |
|
ILB-M51H3 | Mouse | Mouse IL-1 beta / IL-1F2 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
ILA-H525c | Human | Human IL-1 beta / IL-1F2 Protein, Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
ILB-H4110 | Human | Human IL-1 beta / IL-1F2 Protein, premium grade | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
Human IL-1 beta, premium grade (Cat. No. ILB-H4110) stimulates secretion of IFN-γ by NK-92 human natural killer lymphoma cells stimulated with 0.5 ng/mL Human IL-12B&IL-12A Heterodimer Protein, His Tag&Flag Tag (Cat. No. IL2-H4210). The specific activity of Human IL-1 beta, premium grade is > 7.0 × 10^7 IU/mg, which is calibrated against human IL-1 beta WHO International Standard (NIBSC code: 86/680) (Routinely tested).
Human IL-1 RII, Fc Tag (Cat. No. IL2-H4256) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human IL-1 beta, His Tag (Cat. No. ILB-H51H3) with an affinity constant of 0.571 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Edaravone/(+)-2-Decanol | SIM-071201; Y-2 | Approved | Jiangsu Simcere Pharmaceutical Co Ltd | Mainland China | Stroke | Nanjing Simcere Dongyuan Pharmaceutical Co Ltd | 2020-07-29 | Brain Infarction; Intracranial Hemorrhages; Cerebral Hemorrhage; Stroke; Alzheimer Disease; Amyotrophic Lateral Sclerosis | Details | |
PG-201 | PG-201 | Approved | Viromed | Layla | South Korea | Osteoarthritis | Pmg Pharm Co Ltd | 2012-01-01 | Osteoarthritis, Knee; Osteoarthritis | Details |
Thalidomide | NSC-66847; NSC-527179; K-17; VP-02 | Approved | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Mainland China | Leprosy, Lepromatous | Fujimoto Pharmaceutical | 1982-01-01 | Osteosarcoma; Leprosy, Lepromatous; Drug Resistant Epilepsy; Primary Myelofibrosis; Neuroectodermal Tumors, Primitive; Prostatitis; Colorectal Neoplasms; Lymphoma, Mantle-Cell; Sarcoma, Ewing; Retinoblastoma; Waldenstrom Macroglobulinemia; Cholangitis, Sclerosing; HIV Wasting Syndrome; Arachnoiditis; Adenocarcinoma, Clear Cell; Prostatic Neoplasms; Pancreatitis, Chronic; Lymphoma, Follicular; Sarcoma; Xerostomia; Burning Mouth Syndrome; Neoplasm Metastasis; Mycobacterium avium-intracellulare Infection; Vascular Malformations; Amyotrophic Lateral Sclerosis; Melanoma; Carcinoma, Hepatocellular; Leukemia, Lymphocytic, Chronic, B-Cell; Myelodysplastic-Myeloproliferative Diseases; Stomatitis; Erythema Nodosum; Anemia, Sideroblastic; Uterine Neoplasms; Lymphoma, Non-Hodgkin; Glioma; Angiodysplasia; Pelvic Pain; Appendiceal Neoplasms; Lung Neoplasms; Endometrial Neoplasms; Mycobacterium Infections; Gastric Antral Vascular Ectasia; Carcinoid Tumor; Lupus Erythematosus, Discoid; Stomatitis, Aphthous; Rhabdomyosarcoma; | Details | |
Rilonacept | KPL-914; RGN-303 | Approved | Regeneron Pharmaceuticals Inc | Arcalyst | United States | Cryopyrin-Associated Periodic Syndromes | Regeneron Pharmaceuticals Inc | 2008-02-27 | Pericarditis; Renal Insufficiency, Chronic; Inflammation; Gout; Scleroderma, Diffuse; Urticaria; Cryopyrin-Associated Periodic Syndromes; Hearing Loss, Sensorineural; Genetic Diseases, Inborn; Familial Mediterranean Fever; Arthritis, Juvenile; Deficiency of interleukin-1 receptor antagonist; Muckle-Wells Syndrome (MWS); Scleroderma, Systemic; Anemia; Schnitzler Syndrome; Diabetes Mellitus, Type 1; Still's Disease, Adult-Onset | Details |
Diacerein | AC-201; AC-203; Art-50; SF-277; CCP-020; KW-4800; AC-201CR | Approved | Verboril, Art, 安必丁, Artrodar, Artrolyt, Cartivix, Fisiodar | Epidermolysis Bullosa, Junctional; Overweight; Epidermolysis Bullosa Dystrophica; Diabetes Mellitus; Osteoarthritis, Hip; Obesity; Osteoarthritis; Arthritis; Diabetes Complications; Diabetes Mellitus, Type 2; Pemphigoid, Bullous; Osteoarthritis, Knee; Epidermolysis Bullosa; Epidermolysis Bullosa Simplex; Coronavirus Disease 2019 (COVID-19); Insulin Resistance; Non-alcoholic Fatty Liver Disease | Details | |||||
Canakinumab | ACZ-885 | Approved | Novartis Pharma Ag | Ilaris | United States | Cryopyrin-Associated Periodic Syndromes; Muckle-Wells Syndrome (MWS) | Novartis Pharma Ag | 2009-06-17 | Pulmonary Disease, Chronic Obstructive; Hyperimmunoglobulin D syndrome; Mucocutaneous Lymph Node Syndrome; Cryopyrin-Associated Periodic Syndromes; Arthritis, Gouty; Coronavirus Infections; Cognitive Dysfunction; Sarcoidosis, Pulmonary; Alzheimer Disease; Urticaria; Muscular Dystrophy, Duchenne; Primary Myelofibrosis; Dry Eye Syndromes; Lung Neoplasms; Gout; Carcinoma, Non-Small-Cell Lung; Macular Degeneration; Diabetes Mellitus; Behcet Syndrome; Diabetic Retinopathy; Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Peripheral Arterial Disease; Diabetes Mellitus, Type 2; Familial Mediterranean Fever; Hepatitis, Alcoholic; Prediabetic State; Diabetes Mellitus, Type 1; Atherosclerosis; Mevalonate Kinase Deficiency; Anemia; Schnitzler Syndrome; Pyoderma Gangrenosum; Polyarticular Juvenile Idiopathic Arthritis; Still's Disease, Adult-Onset; Polycythemia Vera; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Hereditary Autoinflammatory Diseases; Vasculitis; Chronic Urticaria; | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
lutikizumab | ABT-981 | Phase 2 Clinical | Abbvie Inc | Osteoarthritis, Knee; Hidradenitis Suppurativa; Osteoarthritis | Details |
FL-101 | FL-101 | Phase 1 Clinical | Flame Biosciences Inc | Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Post-surgical adhesions; Tissue Adhesions; Cicatrix | Details |
Efprezimod alfa | CD24-Fc; HAS-CD24; CD24-Fc-IgG; MK-7110; MK7110 | Phase 3 Clinical | Oncoimmune Inc | Leukemia; Hematopoietic stem cell transplantation (HSCT); HIV Infections; Solid tumours; Graft vs Host Disease; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Dyslipidemias; Leukemia, Myeloid, Acute; Melanoma | Details |
Ajulemic acid | DMH-11C; JBT-101; CPL-7075; DMH-THC-11-OIC; CT-3; HU-239; IP-751 | Phase 3 Clinical | Corbus Pharma | Cystic Fibrosis; Lupus Vulgaris; Dermatomyositis; Lupus Erythematosus, Systemic; Scleroderma, Diffuse | Details |
DLX-2323 | DLX-2323 | Phase 1 Clinical | Delenex Therapeutics Ag | Inflammation | Details |
Tavo-103 | Tavo103; Tavo-103; TAVO-103A; TAVO103A | Phase 1 Clinical | Tavotek Biotherapeutics (Hong Kong) Ltd | Details | |
Gevokizumab | XMA-005.2; AB-7; XOMA-052; S-78989; VPM-087 | Phase 1 Clinical | Xoma Corp | Colonic Neoplasms; Labyrinth Diseases; Panuveitis; Behcet Syndrome; Osteoarthritis; Uveitis; Colorectal Neoplasms; Cryopyrin-Associated Periodic Syndromes; Arthritis, Rheumatoid; Diabetes Mellitus, Type 1; Hereditary Autoinflammatory Diseases; Diabetes Mellitus, Type 2; Carcinoma, Renal Cell; Esophageal Neoplasms; Pyoderma Gangrenosum; Stomach Neoplasms; Acne Vulgaris | Details |
AK-114 | AK-114; AK114 | Phase 1 Clinical | Solid tumours; Neoplasms; Inflammation; Neoplasm Metastasis | Details | |
Recombinant humanized monoclonal antibody antiIL-1β(Cp Guojian) | SSGJ-613 | Phase 2 Clinical | Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd | Tumor necrosis factor receptor associated periodic syndrome; Arthritis, Juvenile; Arthritis, Gouty; Gout; Inflammation | Details |
Goflikicept | RPH-104 | Phase 3 Clinical | Trpharm | Still's Disease, Adult-Onset; Familial Mediterranean Fever; ST Elevation Myocardial Infarction; Schnitzler Syndrome; Coronavirus Disease 2019 (COVID-19); Pericarditis; Gout | Details |
CU-06 | CU-06-EYE; CU-06-IBD; CU-061004; Sac-1004; CU-06-ONCO; CU-06-HAE; CU06-1004 | Phase 2 Clinical | Curacle Co Ltd | Myocardial Infarction; Neoplasms; Lung Diseases; Stroke; Diabetic macular oedema; Colitis, Ulcerative; Macular Degeneration; Angioedemas, Hereditary; Crohn Disease; Diabetic Retinopathy | Details |
Kinnazumab | Phase 3 Clinical | Changchun Genescience Pharmaceutical Co Ltd | Solid tumours; Still's Disease, Adult-Onset; Arthritis, Juvenile; Arthritis, Gouty; Gout | Details |
This web search service is supported by Google Inc.